Farmak invested more than $1.2M in HealthCare projects and startups.

According to Farmak director Volodymyr Kostyuk, the company started investing in the venture capital market in 2020. The company is interested in advanced rapid diagnostics, digital medicine, and interactive patient involvement, which diagnoses and predicts possible health problems. After analyzing the venture capital market in Ukraine and abroad, Farmak selected several more startups for investments. One of the investments is in American biotech startup Cambrian Biopharma, which is developing innovative drugs to combat the biological factors of aging, treat and prevent age-related diseases and increase life expectancy.